External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Infectious Disease ESPID 2024
Roche and Genentech at

ESPID 2024

May 20 - May 24
Copenhagen, Denmark / Virtual (Hybrid)
espid.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
08:50 AM
Duration 10mins Hall C1M1
Baloxavir marboxil▼ single-dose treatment in otherwise-healthy children aged <1 year with influenza: results of a single-arm, open-label study (miniSTONE-1)
Palmu S, Pilay-Ramaya L, Baker J, Kocsis K, Galloway D, Wildum S, Macutkiewicz L, Macias Parra M
Infectious Disease | Influenza Virus Infection

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
02:00 PM
Duration 90mins Copenhagen, Denmark / Virtual (Hybrid)
Baloxavir marboxil▼ for the treatment of uncomplicated influenza in children aged <1 year: population pharmacokinetic analysis and exposure matching for extrapolation of efficacy
Retout S, Jolivet S, De Buck S, Delporte M-L
Infectious Disease | Influenza Virus Infection

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.